Literature DB >> 10833254

Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses.

E J Simchuk1, R C Thirlby.   

Abstract

Total colectomy, mucosal proctectomy, and ileal J pouch-anal anastomosis (IPAA) has become the procedure of choice for patients with ulcerative colitis and familial adenomatous polyposis. The purpose of this study was to determine the short- and long-term outcomes of patients undergoing IPAA by a single surgeon, correlating intraoperative technical aspects with outcomes, and to characterize better the clinical syndrome of pouchitis. A retrospective review was performed of 114 consecutive patients who underwent IPAA by a single surgeon between December 1987 and August 1996. Clinical follow-up and operative notes were reviewed, and patient questionnaires were obtained for all patients. The mean follow-up was 3 years (range 0.5-8.0 years). The average age of the patients was 39 years (range 16-72 years). There were 64 males and 50 females. Indications for operation were ulcerative colitis (n = 101) and familial polyposis coli (n = 13). Long-term morbidity occurred in 41% of patients (small bowel obstruction 10%, anastomotic stricture 9%). Pouch excision was required in only three patients. Stool frequency (mean +/- SE) was 6.1 +/- 0.2 and did not change with duration of follow-up. Only 7% of patients reported fecal soilage. The incidence of pouchitis was 59% (n = 67), with 4.2 +/- 0.3 episodes of pouchitis per patient. Using multivariate analysis, the factors significantly associated with the incidence of pouchitis were gender (p = 0.008) and duration of follow-up (p = 0. 02). A total of 37 of 50 women (74%) but only 30 of 64 men (47%) developed pouchitis. The incidence of pouchitis increased with the duration of follow-up. The incidences of pouchitis in patients followed for 6 months, 1 year, and 3 years were 25%, 37%, and 50%, respectively. Of patients followed more than 6 years, the incidence of pouchitis was 94% (15/16). There was not a significant correlation between anastomotic tension or the extent of arterial dissection of the ileal mesentery required to achieve IPAA and the incidence of pouchitis. The best antibiotics for pouchitis were metronidazole (54% of patients) and ciprofloxacin (37%). Eleven patients have required nearly continuous antibiotics. Patient satisfaction with the outcome is high, with a mean satisfaction of 8. 4 (0, dissatisfied; 10, extremely satisfied). This review demonstrates a high incidence of pouchitis in patients after IPAA, which is due to the more liberal definition of the syndrome and the complete follow-up achieved in this report compared to previous series. This study also is unique in identifying the significantly higher incidence of pouchitis in women, although the overall satisfaction with the clinical outcome in patients undergoing IPAA remains high.

Entities:  

Mesh:

Year:  2000        PMID: 10833254     DOI: 10.1007/s002680010136

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis.

Authors:  Orlaith B Kelly; Morgan Rosenberg; Andrea D Tyler; Joanne M Stempak; A Hillary Steinhart; Zane Cohen; Gordon R Greenberg; Mark S Silverberg
Journal:  J Crohns Colitis       Date:  2015-12-30       Impact factor: 9.071

2.  Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis.

Authors:  Lino Polese; Imerio Angriman; De Franchis Giuseppe; Attilio Cecchetto; Giacomo-C Sturniolo; D'Inca Renata; Marco Scarpa; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide-F D'Amico
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

3.  Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis.

Authors:  Bo Shen; Bret Lashner
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

4.  ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.

Authors:  Jennifer A Coukos; Lauren A Howard; Janice M Weinberg; James M Becker; Arthur F Stucchi; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2012-02-07       Impact factor: 3.199

5.  Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: effect on quality of life.

Authors:  Matthias Turina; Connie J Pennington; Jennifer Kimberling; Arnold J Stromberg; Robert E Petras; Susan Galandiuk
Journal:  J Gastrointest Surg       Date:  2006-04       Impact factor: 3.452

Review 6.  Role of surgery in pediatric ulcerative colitis.

Authors:  Emanuela Ceriati; Francesco De Peppo; Massimo Rivosecchi
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

7.  Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Authors:  Edward L Barnes; Hans H Herfarth; Robert S Sandler; Wenli Chen; Elizabeth Jaeger; Van M Nguyen; Amber R Robb; Michael D Kappelman; Christopher F Martin; Millie D Long
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

8.  Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics.

Authors:  Mohei Kohyama; Yoshio Takesue; Hiroki Ohge; Yoshiaki Murakami; Fumio Shimamoto; Taijiro Sueda
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

Review 9.  Role of capsule endoscopy in inflammatory bowel disease.

Authors:  Uri Kopylov; Ernest G Seidman
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Does mesorectal preservation protect the ileoanal anastomosis after restorative proctocolectomy?

Authors:  Andreas D Rink; Irina Radinski; Karl-Heinz Vestweber
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.